Learn About Medicare Coverage and Zepbound for Diabetes

Understanding Medicare Coverage Basics

Medicare is a federal health insurance program designed primarily for people age 65 and older. The program also covers some younger people with disabilities and individuals with end-stage renal disease. Understanding how Medicare works is essential before exploring coverage for specific medications or treatments.

Medicare has four main parts, each covering different services. Part A covers hospital stays, skilled nursing facility care, hospice care, and some home health services. Part B covers doctor visits, outpatient services, medical equipment, and preventive care. Part D covers prescription drugs. Part C, also called Medicare Advantage, is an alternative way to receive Medicare benefits through private insurance companies approved by Medicare.

The program operates on a calendar year basis. Each year from October 15 to December 7, people with Medicare can make changes to their coverage during the Annual Enrollment Period. Outside this window, changes typically require a qualifying life event, such as losing other health coverage or moving to a new state.

Medicare has different costs depending on the type of coverage chosen. Original Medicare (Parts A and B) has monthly premiums, annual deductibles, and copayments or coinsurance. Medicare Advantage plans often have different cost structures, sometimes with lower premiums but potentially higher out-of-pocket costs. Part D prescription drug plans have their own premiums, deductibles, and cost-sharing arrangements.

According to the Centers for Medicare & Medicaid Services (CMS), approximately 66 million people were enrolled in Medicare as of 2023. This large enrollment reflects the program's importance in providing health coverage to older adults and certain other groups.

Practical Takeaway: Before exploring medication coverage, identify which Medicare parts you have. This determines what services and prescriptions your plan covers and what costs you might owe.

How Medicare Part D Covers Prescription Drugs

Medicare Part D is the prescription drug coverage portion of Medicare. This coverage is optional but recommended for people who take regular medications, as those without Part D coverage may face a penalty if they enroll later. Part D is offered through private insurance companies approved by Medicare, and plans vary in which drugs they cover and how much they cost.

Each Part D plan has a formulary—a list of covered medications. Formularies are organized into tiers, typically ranging from 2 to 5 levels. Tier 1 usually includes generic drugs with the lowest costs. Tier 2 includes preferred brand-name drugs. Higher tiers include non-preferred drugs or specialty medications, which have higher out-of-pocket costs. Some drugs may not be on a formulary at all, meaning the plan does not cover them.

Part D coverage has a specific cost structure throughout the year. First, you pay your monthly plan premium. Then, you pay out-of-pocket costs until you reach your annual deductible, which varies by plan but cannot exceed $545 in 2024. After meeting the deductible, you enter the initial coverage stage, where you typically pay a copayment or coinsurance for each prescription.

Once your total out-of-pocket spending reaches a coverage gap threshold (called the "donut hole"), you enter a phase where you pay a higher percentage of drug costs. In 2024, this gap begins at $5,850 in total drug spending. However, the Inflation Reduction Act, which took effect in 2024, introduced significant changes. Medicare now negotiates drug prices directly with manufacturers for certain high-cost drugs, potentially lowering costs for beneficiaries. Additionally, insulin products are capped at $35 per month for Medicare Part D enrollees.

Specialty drugs—medications used to treat complex conditions like certain cancers, rheumatoid arthritis, or multiple sclerosis—are typically subject to higher cost-sharing, sometimes costing 25-33% of the medication price. Some plans may require prior authorization, meaning your doctor must get approval from the insurance company before the medication is covered.

Practical Takeaway: Review your Part D formulary each year during enrollment to confirm your medications are covered and understand your potential costs. Costs and coverage can change annually, and switching plans during the Annual Enrollment Period might reduce your expenses.

Zepbound: What You Should Know About This Medication

Zepbound is a prescription medication containing tirzepatide, a type 2 diabetes treatment that works by mimicking two natural hormones that help regulate blood sugar and appetite. The FDA approved Zepbound specifically for weight management in June 2023. It is injected once weekly under the skin, typically in the abdomen, thigh, or upper arm. The medication comes in a prefilled pen that patients inject themselves at home.

In clinical trials, Zepbound demonstrated significant effects on weight loss. Research published in the New England Journal of Medicine showed that people taking the highest dose of tirzepatide lost approximately 22% of their body weight over 68 weeks, compared to 2.4% in the placebo group. For people with diabetes, tirzepatide also helps lower blood sugar levels. The medication works by increasing insulin release when blood sugar is high and reducing appetite by affecting parts of the brain that control hunger.

Zepbound is not appropriate for everyone. The medication carries a black box warning—the FDA's strongest safety warning—regarding the risk of thyroid tumors and thyroid cancer in animal studies, though this has not been observed in humans. It should not be used by people with a personal or family history of medullary thyroid cancer or by those with multiple endocrine neoplasia syndrome type 2. People with severe kidney disease, stomach problems, or certain eye conditions related to diabetes should discuss Zepbound with their doctor before starting treatment.

Common side effects of Zepbound include nausea, vomiting, diarrhea, constipation, and stomach pain. These side effects often decrease over time as the body adjusts to the medication. More serious but rare side effects can include pancreatitis (inflammation of the pancreas), gallbladder problems, and changes in vision. Because Zepbound can lower blood sugar, people taking other diabetes medications may need dose adjustments.

Treatment with Zepbound is not permanent. When patients stop taking the medication, weight loss is often not maintained. Studies show that people regain much of the weight they lost within about a year of stopping the medication. This means Zepbound is typically intended as a long-term treatment, similar to how people take blood pressure or cholesterol medications continuously.

Practical Takeaway: Zepbound is one tool among several options for managing weight and blood sugar. Discuss with your doctor whether this medication aligns with your health goals and whether you have any conditions that would make it inappropriate for you.

Medicare Coverage of Zepbound: Current Policies and Limitations

Medicare's coverage of Zepbound involves important distinctions between weight loss and diabetes management. Medicare Part D plans may cover tirzepatide when it is prescribed for type 2 diabetes management, as this is an FDA-approved use for blood sugar control. However, Medicare Part D does not cover Zepbound when it is prescribed specifically for weight loss in people without diabetes, even though this is an FDA-approved indication. This distinction is critical because the medication is marketed under the brand name Zepbound for weight management but under the brand name Mounjaro for diabetes treatment—both contain the same active ingredient.

Whether your specific Part D plan covers tirzepatide for diabetes depends on your individual plan's formulary. Not all Medicare Part D plans include tirzepatide on their covered drug lists. Some plans may cover it only at higher cost-sharing tiers, meaning you pay a larger percentage of the drug cost. Other plans might require prior authorization, requiring your doctor to document that you have tried other diabetes medications first or that you have medical reasons to use tirzepatide instead of other options.

Coverage also depends on whether you have Original Medicare with a separate Part D plan or Medicare Advantage coverage. Medicare Advantage plans (Part C) include prescription drug coverage, but their formularies and coverage policies vary by plan. Some Medicare Advantage plans may not cover tirzepatide at all, while others might offer coverage similar to traditional Part D plans.

The cost of tirzepatide outside of insurance coverage is substantial. Without insurance, a month's supply of Zepbound or Mounjaro can cost $1,000 or more, depending on the dose. For people on Medicare, actual costs depend on their specific plan's tier placement for the drug, their deductible status, and whether they have entered